Ren Chi Yang

562 total citations
14 papers, 441 citations indexed

About

Ren Chi Yang is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ren Chi Yang has authored 14 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Ren Chi Yang's work include Angiogenesis and VEGF in Cancer (5 papers), Acute Myeloid Leukemia Research (3 papers) and Platelet Disorders and Treatments (3 papers). Ren Chi Yang is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Acute Myeloid Leukemia Research (3 papers) and Platelet Disorders and Treatments (3 papers). Ren Chi Yang collaborates with scholars based in China, United States and France. Ren Chi Yang's co-authors include Zhongchao Han, Bin Zhou, Hui Zhao, Zongjin Li, Chen Yang, Shi Hong Lu, Hong Jun Li, Bin Xu, Yi Zheng and David T. Scadden and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Leukemia.

In The Last Decade

Ren Chi Yang

13 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren Chi Yang China 10 223 136 130 73 66 14 441
Nagwa S. El‐Badri United States 12 146 0.7× 153 1.1× 231 1.8× 110 1.5× 25 0.4× 24 520
Hengxing Meng China 10 173 0.8× 159 1.2× 82 0.6× 32 0.4× 29 0.4× 20 423
Takeaki Dohda Japan 9 415 1.9× 277 2.0× 60 0.5× 108 1.5× 38 0.6× 12 708
Masahiko Zuka Japan 7 160 0.7× 101 0.7× 80 0.6× 73 1.0× 22 0.3× 15 440
Luisa Milazzo Italy 10 170 0.8× 211 1.6× 115 0.9× 53 0.7× 14 0.2× 18 500
Sateesh Kunigal United States 10 290 1.3× 108 0.8× 102 0.8× 45 0.6× 32 0.5× 19 567
Claire Peghaire United Kingdom 13 356 1.6× 104 0.8× 104 0.8× 41 0.6× 15 0.2× 16 642
Ameet R. Kini United States 14 375 1.7× 177 1.3× 96 0.7× 18 0.2× 41 0.6× 35 597
Yuichi Ohki Japan 4 227 1.0× 75 0.6× 105 0.8× 62 0.8× 22 0.3× 5 484
B. Reufi Germany 14 147 0.7× 165 1.2× 147 1.1× 51 0.7× 47 0.7× 26 593

Countries citing papers authored by Ren Chi Yang

Since Specialization
Citations

This map shows the geographic impact of Ren Chi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Chi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Chi Yang more than expected).

Fields of papers citing papers by Ren Chi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Chi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Chi Yang. The network helps show where Ren Chi Yang may publish in the future.

Co-authorship network of co-authors of Ren Chi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Chi Yang. A scholar is included among the top collaborators of Ren Chi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Chi Yang. Ren Chi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Qin, Shuang, et al.. (2011). [Clinical and laboratory investigation of patients with hematologic malignancies harboring der(1;7)(q10;p10)].. PubMed. 28(4). 441–5. 1 indexed citations
4.
Du, Wei, et al.. (2009). The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Human Immunology. 70(6). 398–402. 19 indexed citations
5.
Zhao, Hui, et al.. (2006). Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Leukemia Research. 30(11). 1341–1345. 17 indexed citations
6.
Li, Zongjin, Zack Z. Wang, Yi Zheng, et al.. (2005). Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation. Journal of Cellular Biochemistry. 95(3). 559–570. 41 indexed citations
7.
Zhou, Bin, Hui Zhao, Ren Chi Yang, & Zhongchao Han. (2005). Multi-dysfunctional pathophysiology in ITP. Critical Reviews in Oncology/Hematology. 54(2). 107–116. 86 indexed citations
8.
Yang, Ren Chi, et al.. (2005). Enhanced growth suppression of Philadephia1 leukemia cells by targeting bcr3/abl2 and VEGF through antisense strategy. Leukemia. 19(9). 1517–1524. 11 indexed citations
9.
Li, Zongjin, et al.. (2005). [In vitro vasculogenesis and angiogenesis of mouse embryonic stem cells].. PubMed. 27(1). 62–6. 1 indexed citations
10.
Han, Zhongchao, Zongjin Li, Zack Z. Wang, et al.. (2004). Unique Expression of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1/CD31) on Embryonic Stem Cells.. Blood. 104(11). 3914–3914.
11.
Yang, Chen, et al.. (2004). Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thrombosis and Haemostasis. 91(6). 1202–1212. 91 indexed citations
12.
13.
Liu, Yong-Jun, Shi Hong Lu, Ren Chi Yang, et al.. (2004). Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood. 103(12). 4449–4456. 55 indexed citations
14.
He, Rui, Bin Liu, Chen Yang, et al.. (2003). Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence. Cancer Gene Therapy. 10(12). 879–886. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagwa S. El‐Badri Breakdown of academic impact, for papers by Hengxing Meng Breakdown of academic impact, for papers by Takeaki Dohda Breakdown of academic impact, for papers by Masahiko Zuka Breakdown of academic impact, for papers by Luisa Milazzo Breakdown of academic impact, for papers by Sateesh Kunigal Breakdown of academic impact, for papers by Claire Peghaire Breakdown of academic impact, for papers by Ameet R. Kini Breakdown of academic impact, for papers by Yuichi Ohki Breakdown of academic impact, for papers by B. Reufi
Rankless by CCL
2026